Physiol. Genomics Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics (December 28, 2004). doi:10.1152/physiolgenomics.00226.2004
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Tables
Right arrow All Versions of this Article:
21/1/34    most recent
00226.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kong, S. W.
Right arrow Articles by Kang, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kong, S. W.
Right arrow Articles by Kang, P. M.
Submitted on September 29, 2004
Accepted on December 22, 2004

Genetic Expression Profiles During Physiologic and Pathologic Cardiac Hypertrophy and Heart Failure in Rats

Sek Won Kong, Natalya Bodyak, Patrick Yue, Zhilin Liu, Jeffrey Brown, Seigo Izumo, and Peter M. Kang*

* To whom correspondence should be addressed. E-mail: pkang{at}bidmc.harvard.edu.

Cardiac hypertrophy is a complex and non-homogenous response to various stimuli. In this study, we used high-density oligonucleotide microarray to examine gene expression profiles during physiologic hypertrophy, pathologic hypertrophy, and heart failure in Dahl salt-sensitive rats. There were changes in 404/3160 and 874/3160 genes between physiologic vs. pathologic hypertrophy and the transition from hypertrophy to heart failure, respectively. There were increases in stress response genes (e.g. heat shock proteins) and inflammation-related genes (e.g. PAP and Alox12) in pathologic processes but not in physiologic hypertrophy. Furthermore, atrial natriuretic factor (ANF) and brain natriuretic protein (BNP) showed distinctive changes that are very specific to different conditions. In addition, we used resampling-based gene score calculating method to define significantly altered gene clusters based on Gene Ontology (GO) classification. It revealed significant alterations in genes involved in the apoptosis pathway during pathologic hypertrophy suggesting that the apoptosis pathway may play a role during the transition to heart failure. In addition, there were significant changes in glucose/insulin signaling, protein biosynthesis and epidermal growth factor signaling during physiologic hypertrophy, but not during pathologic hypertrophy.




This article has been cited by other articles:


Home page
J. Immunol.Home page
D. Viterbo, M. H. Bluth, Y.-y. Lin, C. M. Mueller, R. Wadgaonkar, and M. E. Zenilman
Pancreatitis-Associated Protein 2 Modulates Inflammatory Responses in Macrophages
J. Immunol., August 1, 2008; 181(3): 1948 - 1958.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J.-L. Samuel, M. C. Schaub, M. Zaugg, M. Mamas, W. B. Dunn, and B. Swynghedauw
Genomics in cardiac metabolism
Cardiovasc Res, July 15, 2008; 79(2): 218 - 227.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Koyanagi, L. Y. Wong, K. Inagaki, O. V. Petrauskene, and D. Mochly-Rosen
Alteration of gene expression during progression of hypertension-induced cardiac dysfunction in rats
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H220 - H226.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. K.R. Soppa, J. Lee, M. A. Stagg, L. E. Felkin, P. J.R. Barton, U. Siedlecka, S. Youssef, M. H. Yacoub, and C. M.N. Terracciano
Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure
Cardiovasc Res, March 1, 2008; 77(4): 695 - 706.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Sena, I. R. Rasmussen, A. R. Wende, A. P. McQueen, H. A. Theobald, N. Wilde, R. O. Pereira, S. E. Litwin, J. P. Berger, and E. D. Abel
Cardiac Hypertrophy Caused by Peroxisome Proliferator- Activated Receptor-{gamma} Agonist Treatment Occurs Independently of Changes in Myocardial Insulin Signaling
Endocrinology, December 1, 2007; 148(12): 6047 - 6053.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Bupha-Intr, J. W. Holmes, and P. M. L. Janssen
Induction of hypertrophy in vitro by mechanical loading in adult rabbit myocardium
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3759 - H3767.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Bodyak, J. C. Ayus, S. Achinger, V. Shivalingappa, Q. Ke, Y.-S. Chen, D. L. Rigor, I. Stillman, H. Tamez, P. E. Kroeger, et al.
Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals
PNAS, October 23, 2007; 104(43): 16810 - 16815.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Bodyak, D. L. Rigor, Y.-S. Chen, Y. Han, E. Bisping, W. T. Pu, and P. M. Kang
Uncoupling protein 2 modulates cell viability in adult rat cardiomyocytes
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H829 - H835.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. W. Dorn II
The Fuzzy Logic of Physiological Cardiac Hypertrophy
Hypertension, May 1, 2007; 49(5): 962 - 970.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Ashrafian and H. Watkins
Reviews of Translational Medicine and Genomics in Cardiovascular Disease: New Disease Taxonomy and Therapeutic Implications: Cardiomyopathies: Therapeutics Based on Molecular Phenotype
J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1251 - 1264.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. C. Okere, M. E. Young, T. A. McElfresh, D. J. Chess, V. G. Sharov, H. N. Sabbah, B. D. Hoit, P. Ernsberger, M. P. Chandler, and W. C. Stanley
Low Carbohydrate/High-Fat Diet Attenuates Cardiac Hypertrophy, Remodeling, and Altered Gene Expression in Hypertension
Hypertension, December 1, 2006; 48(6): 1116 - 1123.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. Rajan, S. S. Williams, G. Jagatheesan, R. P. H. Ahmed, G. Fuller-Bicer, A. Schwartz, B. J. Aronow, and D. F. Wieczorek
Microarray analysis of gene expression during early stages of mild and severe cardiac hypertrophy
Physiol Genomics, November 21, 2006; 27(3): 309 - 317.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Bisping, S. Ikeda, S. W. Kong, O. Tarnavski, N. Bodyak, J. R. McMullen, S. Rajagopal, J. K. Son, Q. Ma, Z. Springer, et al.
Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure
PNAS, September 26, 2006; 103(39): 14471 - 14476.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. W. Dorn II
Containing Hypertrophy With a PICOT Fence
Circ. Res., August 4, 2006; 99(3): 228 - 230.
[Full Text] [PDF]


Home page
Physiol. GenomicsHome page
M. Liang and B. Ventura
Physiological genomics in PG and beyond: July to September 2005
Physiol Genomics, October 17, 2005; 23(2): 119 - 124.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.